The World Health Assembly , “Strengthening clinical trials to provide
high-quality evidence on health interventions and to improve research quality
and coordination”, was adopted by the 75th World Health Assembly in May 2022.
WHO is developing best practice guidance following the direction of the
resolution, highlighting the key scientific and ethical considerations in
clinical trial design and implementation, strengthening clinical trial
ecosystems, and addressing underserved subpopulations in clinical trials.
A survey has been developed as one of
the modalities for a series of consultations for the implementation of WHA
75.8. The inputs collected from this survey will help to inform the next steps
of our engagement, at global, regional, and country levels to gather further
input to the guidance and inform WHO’s support to Member States and non-state
actors in the implementation of best practices for clinical trials.
